Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Bioorg Med Chem Lett. 2019 May 23;29(15):1985–1993. doi: 10.1016/j.bmcl.2019.05.024

Table 4:

FMF-03-198 analogs with a modified heterocyclic core. A) CDK14 IC50s were measured using a LanthaScreen binding assay. IC50s were calculated as the average of three replicates, and are reported ± the standard error. B) Antiproliferative activity against the HCT116 cell line was measured using a CellTiter-Glo assay. IC50s were calculated as the average of three replicates, and are reported ± the standard error.

graphic file with name nihms-1531467-t0006.jpg